Migraine clinical trials in Georgia
11 studies for Migraine are looking for participants at sites in Georgia.
Cities in Georgia
Study of EVO756 in Adults With Migraine
- Clinical Integrative Research Center of Atlanta, Atlanta
- Accel Research Site-Decatur-Alcanza, Decatur
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Nov 13, 2026 · NCT07616128A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Clinical Integrative Research Center of Atlanta, Atlanta
- Evergreen Clinical Trials, Norcross
- Velocity Clinical Research, Savannah, Savannah
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07816367A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- DelRicht Research, Atlanta
- Drug Studies America, Marietta
- Sleep Care Research Institute d/b/a Clinical Research Atlanta-Stockbridge, Stockbridge
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 2, 2026 · NCT07645924Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- CenExel iResearch, LLC, Decatur
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 27, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- CenExel iResearch, LLC, Decatur
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 27, 2026 · NCT04649242Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Clinical Trial Office, Augusta
- Augusta University, Augusta
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 14, 2026 · NCT05156398Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Conquest Research, Atlanta
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Oct 9, 2026 · NCT07646613A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Coastal Heritage Clinical Research, Hinesville
RecruitingPhase 1
Ages 6 to 11 · All sexes · Updated Sep 28, 2026 · NCT06995729Responding With Evidence and Access for Childhood Headaches
- Clinical Integrative Research Center of Atlanta, Inc, Atlanta
Recruiting
Ages 10 to 17 · All sexes · Updated Sep 21, 2026 · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Rare Disease Research /ID# 231046, Atlanta
- Clinical Integrative Research Center of Atlanta (CIRCA) /ID# 231134, Atlanta
- Coastal Georgia Child Neurology /ID# 231409, Brunswick
- and 1 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
- Vista Clinical Research, Newnan
Recruiting
Ages 22 to 84 · All sexes · Updated Aug 28, 2026 · NCT07719608From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.